• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

G蛋白偶联受体中从G蛋白到激动剂结合口袋的变构偶联。

Allosteric coupling from G protein to the agonist-binding pocket in GPCRs.

作者信息

DeVree Brian T, Mahoney Jacob P, Vélez-Ruiz Gisselle A, Rasmussen Soren G F, Kuszak Adam J, Edwald Elin, Fung Juan-Jose, Manglik Aashish, Masureel Matthieu, Du Yang, Matt Rachel A, Pardon Els, Steyaert Jan, Kobilka Brian K, Sunahara Roger K

出版信息

Nature. 2016 Jul 7;535(7610):182-6. doi: 10.1038/nature18324. Epub 2016 Jun 29.

DOI:10.1038/nature18324
PMID:27362234
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5702553/
Abstract

G-protein-coupled receptors (GPCRs) remain the primary conduit by which cells detect environmental stimuli and communicate with each other. Upon activation by extracellular agonists, these seven-transmembrane-domain-containing receptors interact with heterotrimeric G proteins to regulate downstream second messenger and/or protein kinase cascades. Crystallographic evidence from a prototypic GPCR, the β2-adrenergic receptor (β2AR), in complex with its cognate G protein, Gs, has provided a model for how agonist binding promotes conformational changes that propagate through the GPCR and into the nucleotide-binding pocket of the G protein α-subunit to catalyse GDP release, the key step required for GTP binding and activation of G proteins. The structure also offers hints about how G-protein binding may, in turn, allosterically influence ligand binding. Here we provide functional evidence that G-protein coupling to the β2AR stabilizes a ‘closed’ receptor conformation characterized by restricted access to and egress from the hormone-binding site. Surprisingly, the effects of G protein on the hormone-binding site can be observed in the absence of a bound agonist, where G-protein coupling driven by basal receptor activity impedes the association of agonists, partial agonists, antagonists and inverse agonists. The ability of bound ligands to dissociate from the receptor is also hindered, providing a structural explanation for the G-protein-mediated enhancement of agonist affinity, which has been observed for many GPCR–G-protein pairs. Our data also indicate that, in contrast to agonist binding alone, coupling of a G protein in the absence of an agonist stabilizes large structural changes in a GPCR. The effects of nucleotide-free G protein on ligand-binding kinetics are shared by other members of the superfamily of GPCRs, suggesting that a common mechanism may underlie G-protein-mediated enhancement of agonist affinity.

摘要

G蛋白偶联受体(GPCRs)仍然是细胞检测环境刺激并相互通讯的主要途径。在细胞外激动剂激活后,这些含有七个跨膜结构域的受体与异源三聚体G蛋白相互作用,以调节下游第二信使和/或蛋白激酶级联反应。来自典型GPCR——β2肾上腺素能受体(β2AR)与其同源G蛋白Gs复合物的晶体学证据,为激动剂结合如何促进构象变化提供了一个模型,这种构象变化通过GPCR传播到G蛋白α亚基的核苷酸结合口袋,以催化GDP释放,这是GTP结合和G蛋白激活所需的关键步骤。该结构还暗示了G蛋白结合如何反过来变构影响配体结合。在这里,我们提供了功能证据,表明G蛋白与β2AR的偶联稳定了一种“封闭”的受体构象,其特征是进入和离开激素结合位点受到限制。令人惊讶的是,在没有结合激动剂的情况下也能观察到G蛋白对激素结合位点的影响,其中由基础受体活性驱动的G蛋白偶联会阻碍激动剂、部分激动剂、拮抗剂和反向激动剂的结合。结合的配体与受体解离的能力也受到阻碍这为G蛋白介导的激动剂亲和力增强提供了结构解释,这在许多GPCR - G蛋白对中都已观察到。我们的数据还表明,与单独的激动剂结合不同,在没有激动剂的情况下G蛋白的偶联稳定了GPCR中的大结构变化。无核苷酸G蛋白对配体结合动力学的影响在GPCR超家族的其他成员中也有体现,这表明一种共同机制可能是G蛋白介导的激动剂亲和力增强的基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eee/5702553/4b4d539501b4/nihms787243f15.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eee/5702553/4eee10f7552b/nihms787243f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eee/5702553/90acfa937412/nihms787243f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eee/5702553/49878cf8e68f/nihms787243f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eee/5702553/e76d5d97ec3d/nihms787243f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eee/5702553/7722b1bcba04/nihms787243f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eee/5702553/82fb0e77e2bf/nihms787243f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eee/5702553/45e07400a8df/nihms787243f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eee/5702553/804616113138/nihms787243f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eee/5702553/842dc4333b8d/nihms787243f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eee/5702553/f39eea89a55b/nihms787243f10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eee/5702553/32e4f2d57b5c/nihms787243f11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eee/5702553/d0d6bb7aa9ce/nihms787243f12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eee/5702553/2e431516c812/nihms787243f13.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eee/5702553/124519fd4c11/nihms787243f14.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eee/5702553/4b4d539501b4/nihms787243f15.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eee/5702553/4eee10f7552b/nihms787243f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eee/5702553/90acfa937412/nihms787243f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eee/5702553/49878cf8e68f/nihms787243f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eee/5702553/e76d5d97ec3d/nihms787243f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eee/5702553/7722b1bcba04/nihms787243f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eee/5702553/82fb0e77e2bf/nihms787243f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eee/5702553/45e07400a8df/nihms787243f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eee/5702553/804616113138/nihms787243f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eee/5702553/842dc4333b8d/nihms787243f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eee/5702553/f39eea89a55b/nihms787243f10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eee/5702553/32e4f2d57b5c/nihms787243f11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eee/5702553/d0d6bb7aa9ce/nihms787243f12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eee/5702553/2e431516c812/nihms787243f13.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eee/5702553/124519fd4c11/nihms787243f14.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eee/5702553/4b4d539501b4/nihms787243f15.jpg

相似文献

1
Allosteric coupling from G protein to the agonist-binding pocket in GPCRs.G蛋白偶联受体中从G蛋白到激动剂结合口袋的变构偶联。
Nature. 2016 Jul 7;535(7610):182-6. doi: 10.1038/nature18324. Epub 2016 Jun 29.
2
Allosteric nanobodies reveal the dynamic range and diverse mechanisms of G-protein-coupled receptor activation.变构纳米抗体揭示了G蛋白偶联受体激活的动态范围和多种机制。
Nature. 2016 Jul 21;535(7612):448-52. doi: 10.1038/nature18636. Epub 2016 Jul 13.
3
Single-molecule analysis of ligand efficacy in βAR-G-protein activation.β肾上腺素能受体(βAR)-G蛋白激活中配体效能的单分子分析
Nature. 2017 Jul 6;547(7661):68-73. doi: 10.1038/nature22354. Epub 2017 Jun 7.
4
Functional differences between full and partial agonists: evidence for ligand-specific receptor conformations.完全激动剂与部分激动剂之间的功能差异:配体特异性受体构象的证据
J Pharmacol Exp Ther. 2001 Jun;297(3):1218-26.
5
Conformational changes in the G protein Gs induced by the β2 adrenergic receptor.β2 肾上腺素受体诱导 G 蛋白 Gs 的构象变化。
Nature. 2011 Sep 28;477(7366):611-5. doi: 10.1038/nature10488.
6
Structure-Based Prediction of G-Protein-Coupled Receptor Ligand Function: A β-Adrenoceptor Case Study.基于结构的 G 蛋白偶联受体配体功能预测:β-肾上腺素能受体案例研究。
J Chem Inf Model. 2015 May 26;55(5):1045-61. doi: 10.1021/acs.jcim.5b00066. Epub 2015 May 1.
7
Mechanism of intracellular allosteric βAR antagonist revealed by X-ray crystal structure.X射线晶体结构揭示细胞内变构β肾上腺素能受体拮抗剂的作用机制
Nature. 2017 Aug 24;548(7668):480-484. doi: 10.1038/nature23652. Epub 2017 Aug 16.
8
Development and characterization of pepducins as Gs-biased allosteric agonists.作为Gs偏向性变构激动剂的肽模拟物的开发与表征。
J Biol Chem. 2014 Dec 26;289(52):35668-84. doi: 10.1074/jbc.M114.618819. Epub 2014 Nov 13.
9
Small-Molecule Positive Allosteric Modulators of the -Adrenoceptor Isolated from DNA-Encoded Libraries.从 DNA 编码文库中分离出的 -肾上腺素受体的小分子正变构调节剂。
Mol Pharmacol. 2018 Aug;94(2):850-861. doi: 10.1124/mol.118.111948. Epub 2018 May 16.
10
GDP Release from the Open Conformation of Gα Requires Allosteric Signaling from the Agonist-Bound Human β Adrenergic Receptor.GDP 从 Gα 的开放构象释放需要来自激动剂结合的人β肾上腺素能受体的变构信号。
J Chem Inf Model. 2020 Aug 24;60(8):4064-4075. doi: 10.1021/acs.jcim.0c00432. Epub 2020 Aug 11.

引用本文的文献

1
Multicolored sequential resonance energy transfer for detection of simultaneous ligand binding at G protein-coupled receptors.用于检测G蛋白偶联受体上同时发生的配体结合的多色序列共振能量转移
Nat Commun. 2025 Jul 11;16(1):6413. doi: 10.1038/s41467-025-61690-5.
2
Development of an allosteric adhesion GPCR nanobody with therapeutic potential.具有治疗潜力的变构粘附G蛋白偶联受体纳米抗体的开发。
Nat Chem Biol. 2025 May 15. doi: 10.1038/s41589-025-01896-2.
3
Identification of a Lipid-Exposed Extrahelical Binding Site for Positive Allosteric Modulators of the Dopamine D Receptor.

本文引用的文献

1
Structural insights into µ-opioid receptor activation.μ-阿片受体激活的结构见解
Nature. 2015 Aug 20;524(7565):315-21. doi: 10.1038/nature14886. Epub 2015 Aug 5.
2
Structural prerequisites for G-protein activation by the neurotensin receptor.神经降压素受体激活G蛋白的结构前提条件。
Nat Commun. 2015 Jul 24;6:7895. doi: 10.1038/ncomms8895.
3
Allosteric sodium in class A GPCR signaling.A类G蛋白偶联受体信号传导中的变构钠
鉴定多巴胺D受体正变构调节剂的脂质暴露螺旋外结合位点
ACS Chem Neurosci. 2025 Jun 18;16(12):2295-2311. doi: 10.1021/acschemneuro.5c00105. Epub 2025 May 15.
4
Further In Vitro and Ex Vivo Pharmacological and Kinetic Characterizations of CCF219B: A Positive Allosteric Modulator of the α-Adrenergic Receptor.CCF219B的进一步体外和离体药理学及动力学特性:一种α-肾上腺素能受体的正变构调节剂
Pharmaceuticals (Basel). 2025 Mar 27;18(4):476. doi: 10.3390/ph18040476.
5
Domain coupling in activation of a family C GPCR.C类G蛋白偶联受体激活过程中的结构域偶联
Nat Chem Biol. 2025 Apr 25. doi: 10.1038/s41589-025-01895-3.
6
Characterization of [H]Propionylated Human Peptide YY-A New Probe for Neuropeptide Y Y Receptor Binding Studies.[H]丙酰化人肽YY的表征——一种用于神经肽Y Y受体结合研究的新型探针
ACS Pharmacol Transl Sci. 2025 Feb 25;8(3):785-799. doi: 10.1021/acsptsci.4c00666. eCollection 2025 Mar 14.
7
Visualizing agonist-induced M2 receptor activation regulated by aromatic ring dynamics.可视化由芳环动力学调控的激动剂诱导的M2受体激活。
Proc Natl Acad Sci U S A. 2025 Mar 11;122(10):e2418559122. doi: 10.1073/pnas.2418559122. Epub 2025 Mar 7.
8
Molecular simulations reveal intricate coupling between agonist-bound β-adrenergic receptors and G protein.分子模拟揭示了激动剂结合的β-肾上腺素能受体与G蛋白之间的复杂耦合。
iScience. 2025 Jan 2;28(2):111741. doi: 10.1016/j.isci.2024.111741. eCollection 2025 Feb 21.
9
Structure and function of a near fully-activated intermediate GPCR-Gαβγ complex.一种接近完全激活的中间态G蛋白偶联受体-Gαβγ复合物的结构与功能
Nat Commun. 2025 Jan 28;16(1):1100. doi: 10.1038/s41467-025-56434-4.
10
Charge Movements and Conformational Changes: Biophysical Properties and Physiology of Voltage-Dependent GPCRs.电荷移动与构象变化:电压依赖性G蛋白偶联受体的生物物理特性与生理学
Biomolecules. 2024 Dec 23;14(12):1652. doi: 10.3390/biom14121652.
Trends Biochem Sci. 2014 May;39(5):233-44. doi: 10.1016/j.tibs.2014.03.002. Epub 2014 Apr 21.
4
Activation and allosteric modulation of a muscarinic acetylcholine receptor.毒蕈碱型乙酰胆碱受体的激活和变构调节。
Nature. 2013 Dec 5;504(7478):101-6. doi: 10.1038/nature12735. Epub 2013 Nov 20.
5
Adrenaline-activated structure of β2-adrenoceptor stabilized by an engineered nanobody.β2-肾上腺素受体的肾上腺素激活结构由工程纳米抗体稳定。
Nature. 2013 Oct 24;502(7472):575-579. doi: 10.1038/nature12572. Epub 2013 Sep 22.
6
Conformational biosensors reveal GPCR signalling from endosomes.构象型生物传感器揭示内体中的 G 蛋白偶联受体信号转导。
Nature. 2013 Mar 28;495(7442):534-8. doi: 10.1038/nature12000. Epub 2013 Mar 20.
7
Structure of the agonist-bound neurotensin receptor.激动剂结合神经降压素受体的结构。
Nature. 2012 Oct 25;490(7421):508-13. doi: 10.1038/nature11558. Epub 2012 Oct 10.
8
Crystal structure of the µ-opioid receptor bound to a morphinan antagonist.μ-阿片受体与吗啡喃拮抗剂结合的晶体结构
Nature. 2012 Mar 21;485(7398):321-6. doi: 10.1038/nature10954.
9
Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist.人源 M2 毒蕈碱型乙酰胆碱受体与拮抗剂结合的结构。
Nature. 2012 Jan 25;482(7386):547-51. doi: 10.1038/nature10753.
10
Conformational changes in the G protein Gs induced by the β2 adrenergic receptor.β2 肾上腺素受体诱导 G 蛋白 Gs 的构象变化。
Nature. 2011 Sep 28;477(7366):611-5. doi: 10.1038/nature10488.